NCT07516938

Brief Summary

The aim of the present study is to investigate the protective effect of minimal invasive versus the conventional extracorporeal circulation on tissue homeostasis as evidenced by the preservation of tissue metabolism and cerebral perfusion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2025

Completed
8 months until next milestone

First Posted

Study publicly available on registry

April 8, 2026

Completed
Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

3 years

First QC Date

August 12, 2025

Last Update Submit

April 3, 2026

Conditions

Keywords

cardiopulmonary bypassminimal invasive extracorporeal circulationextracorporeal circulationtissue oximetrynear-infrared spectroscopy

Outcome Measures

Primary Outcomes (1)

  • Tissue hypoperfusion severity

    Area under the curve (AUC) where tissue oxygen delivery indexed (DO2i) remains below the critical value of 280 ml/min/m2.

    During surgery, from initiation of cardiopulmonary bypass to weaning of cardiopulmonary bypass

Secondary Outcomes (11)

  • Perfusion ratio derangement

    During surgery from initiation of extracorporeal circulation to weaning of extracorporeal circulation.

  • Cerebral hypoperfusion

    During surgery, from initiation to weaning of extracorporeal circulation

  • Overall mortality

    From surgery to 30 days postoperatively

  • Major adverse cardiac and cerebrovascular events

    From surgery to 30 days postoperatively

  • Renal failure

    From surgery to 30 days postoperatively

  • +6 more secondary outcomes

Study Arms (2)

Minimal Invasive Extracorporeal Circulation (MiECC)

EXPERIMENTAL

Patients undergoing cardiac surgery with Minimal Invasive Extracorporeal Circulation

Device: Real-time tissue oximetry monitoring

Conventional Cardiopulmonary Bypass (cCPB)

ACTIVE COMPARATOR

Patients undergoing cardiac surgery with conventional cardiopulmonary bypass

Device: Real-time tissue oximetry monitoring

Interventions

Real-time tissue metabolism as indicated by oxygen delivery (DO2), oxygen consumption (VO2), oxygen extraction ratio (O2ER), CO2 consumption (VCO2), arterial and mixed venous saturation (SvO2)

Conventional Cardiopulmonary Bypass (cCPB)Minimal Invasive Extracorporeal Circulation (MiECC)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients undergoing undergoing open heart surgery with accepted indications under extracorporeal circulation

You may not qualify if:

  • need for emergency surgery
  • surgery on the thoracic aorta
  • severe co-morbities causing anemia, immunosuppression etc.
  • immunocompromised patients
  • inability to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiothoracic Department, Artistotle University of Thessaloniki School of Medicine

Thessaloniki, Greece

Location

Related Publications (4)

  • Anastasiadis K, Antonitsis P, Asteriou C, Deliopoulos A, Argiriadou H. Modular minimally invasive extracorporeal circulation ensures perfusion safety and technical feasibility in cardiac surgery; a systematic review of the literature. Perfusion. 2022 Nov;37(8):852-862. doi: 10.1177/02676591211026514. Epub 2021 Jun 17.

    PMID: 34137323BACKGROUND
  • Anastasiadis K, Antonitsis P, Deliopoulos A, Argiriadou H. Perfusion matters, and it will always matter in cardiac surgery. Perfusion. 2021 Oct;36(7):677-678. doi: 10.1177/02676591211025154. Epub 2021 Jun 19. No abstract available.

    PMID: 34148398BACKGROUND
  • Angelini GD, Reeves BC, Culliford LA, Maishman R, Rogers CA, Anastasiadis K, Antonitsis P, Argiriadou H, Carrel T, Keller D, Liebold A, Ashkaniani F, El-Essawi A, Breitenbach I, Lloyd C, Bennett M, Cale A, Gunaydin S, Gunertem E, Oueida F, Yassin IM, Serrick C, Murkin JM, Rao V, Moscarelli M, Condello I, Punjabi P, Rajakaruna C, Deliopoulos A, Bone D, Lansdown W, Moorjani N, Dennis S. Conventional versus minimally invasive extra-corporeal circulation in patients undergoing cardiac surgery: A randomized controlled trial (COMICS). Perfusion. 2025 Apr;40(3):730-741. doi: 10.1177/02676591241258054. Epub 2024 Jun 4.

    PMID: 38832503BACKGROUND
  • Antonitsis P, Argiriadou H, Gkiouliava A, Deliopoulos A, Mimikos S, Gilou S, Sarridou D, Voucharas C, Karapanagiotidis G, Anastasiadis K. The value of cerebral and somatic near-infrared spectroscopy within an integrated tissue perfusion monitoring strategy in cardiac surgery: A prospective pilot study. Perfusion. 2026 Jan;41(1):69-79. doi: 10.1177/02676591251340942. Epub 2025 May 8.

    PMID: 40338150BACKGROUND

Study Officials

  • Kyriakos Anastasiadis, MD, PhD, FETCS

    Aristotle University Of Thessaloniki

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: All eligible patients will be randomized with computer-generated algorithm to receive cardiac surgery with minimal invasive versus conventional extracorporeal circulation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Cardiac Surgery

Study Record Dates

First Submitted

August 12, 2025

First Posted

April 8, 2026

Study Start

January 1, 2022

Primary Completion

December 31, 2024

Study Completion

January 31, 2025

Last Updated

April 8, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations